Beneficial ownership — 13D / 13G
87,339 recent Schedule 13D / 13G filings — activist (13D) and passive (13G) stakes above 5% of a class.
Coverage begins December 2024, when the SEC required these schedules to be filed as structured XML.
| Reporting person | Issuer | Schedule | % of class | Event date | Filed |
|---|---|---|---|---|---|
| Saba Capital Management, L.P. | VTN Invesco Trust for Investment Grade New York Municipals | 13D/A | 14.07% | Mar 4, 2024 | 2y |
| PW Partners Atlas Fund IV LP | BJRI BJs RESTAURANTS INC | 13D | 5.2% | Mar 4, 2024 | 2y |
| Advent International, L.P. | CCC CCC Intelligent Solutions Holdings Inc. | 13D/A | 36.8% | Mar 4, 2024 | 2y |
| RA CAPITAL MANAGEMENT, L.P. | JANX Janux Therapeutics, Inc. | 13D/A | 19.99% | Mar 4, 2024 | 2y |
| Angeliki Frangou | NMM Navios Maritime Partners L.P. | 13D/A | 16.7% | Mar 4, 2024 | 2y |
| Fund 1 Investments, LLC | BJRI BJs RESTAURANTS INC | 13D/A | 9.96% | Mar 4, 2024 | 2y |
| William Bennett Nance, Jr. | HGAS Global Gas Corp | 13D/A | 26.9% | Mar 4, 2024 | 2y |
| Abel Avellan | ASTS AST SpaceMobile, Inc. | 13D/A | 36.2% | Mar 4, 2024 | 2y |
| Series R of UM Partners LLC | UTZ Utz Brands, Inc. | 13D/A | 36.1% | Mar 4, 2024 | 2y |
| 2014 Scesaplana I Trust | ASTS AST SpaceMobile, Inc. | 13D/A | 7.6% | Mar 4, 2024 | 2y |
| William J. Quinn | PR Permian Resources Corp | 13D/A | 11.6% | Mar 4, 2024 | 2y |
| RA CAPITAL MANAGEMENT, L.P. | ETNB 89bio, Inc. Common Stock | 13D/A | 14.8% | Mar 4, 2024 | 2y |
| Silver Lake Group, L.L.C. | DELL Dell Technologies Inc. | 13D/A | 23.2% | Mar 4, 2024 | 2y |
| Michael B. Chancellor | LIPO Lipella Pharmaceuticals Inc. | 13D/A | 18.9% | Mar 4, 2024 | 2y |
| Lind Global Fund II LP | OGEN Oragenics Inc | 13G | 5.9% | Mar 1, 2024 | 2y |
| River Road Asset Management, LLC | TBRG TruBridge, Inc. | 13G/A | 4.3% | Feb 29, 2024 | 2y |
| ROYCE & ASSOCIATES LP | GCMG GCM Grosvenor Inc. | 13G/A | 10.79% | Feb 29, 2024 | 2y |
| FEDERATED HERMES, INC. | AMPH Amphastar Pharmaceuticals, Inc. | 13G/A | 4.52% | Feb 29, 2024 | 2y |
| FEDERATED HERMES, INC. | MRUS Merus N.V. Common Shares | 13G/A | 3.98% | Feb 29, 2024 | 2y |
| AWM Investment Company, Inc. | GENK GEN Restaurant Group, Inc. | 13G/A | 0% | Feb 29, 2024 | 2y |
| River Road Asset Management, LLC | SP SP Plus Corporation | 13G/A | 2.9% | Feb 29, 2024 | 2y |
| BAILLIE GIFFORD & CO | CPNG Coupang, Inc. | 13G/A | 10.3% | Feb 29, 2024 | 2y |
| JENNISON ASSOCIATES LLC | ARQT Arcutis Biotherapeutics, Inc. | 13G/A | 10.8% | Feb 29, 2024 | 2y |
| Wolf Hill Capital Management, LP | DBRHP DigitalBridge Group, Inc. | 13G/A | 4.9% | Feb 28, 2024 | 2y |
| Vector Capital Management, L.P. | LPSN Liveperson Inc | 13D | 12.37% | Feb 28, 2024 | 2y |
| Mitchell P. Kopin | ACON Aclarion, Inc. | 13G | 4.99% | Feb 26, 2024 | 2y |
| EVGI Limited | CCTSF Cactus Acquisition Corp. 1 Ltd | 13D | 49.85% | Feb 23, 2024 | 2y |
| Dale Broadrick | BRTX BioRestorative Therapies, Inc. | 13D/A | 14.1% | Feb 8, 2024 | 2y |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | TUP Tupperware Brands Corporation | 13G/A | 10.01% | Feb 1, 2024 | 2y |
| Axim Planning & Wealth | EH EHang Holdings Ltd | 13G | 6.14% | Dec 31, 2023 | 2y |
| PERCEPTIVE ADVISORS LLC | RLMD Relmada Therapeutics, Inc. | 13G/A | 0% | Dec 31, 2022 | 2y |
| Satter Muneer A | RNTX Rein Therapeutics, Inc. | 13D/A | 5.9% | Mar 5, 2024 | 2y |
| SIT INVESTMENT ASSOCIATES INC | JMM Nuveen Multi-Market Income Fund | 13G/A | 56.63% | Mar 5, 2024 | 2y |
| SIT INVESTMENT ASSOCIATES INC | DHY Ubs Asset Management High Yield Credit Fund | 13G/A | 4.82% | Mar 5, 2024 | 2y |
| SCLX Stock Acquisition JV LLC | SCLX Scilex Holding Co | 13D/A | 36.4% | Mar 5, 2024 | 2y |
| FJ Capital Management LLC | HTBK HERITAGE COMMERCE CORP | 13G | 5.24% | Mar 4, 2024 | 2y |
| SIT INVESTMENT ASSOCIATES INC | FMY First Trust Mortgage Income Fund | 13D/A | 53.99% | Mar 4, 2024 | 2y |
| George Economou | SHIP Seanergy Maritime Holdings Corp. | 13D/A | 9.5% | Mar 4, 2024 | 2y |
| Blackstone Inc. | BMBL Bumble Inc. | 13D/A | 35.8% | Mar 3, 2024 | 2y |
| SPRUCE HOUSE INVESTMENT MANAGEMENT LLC | CMPR CIMPRESS plc | 13D/A | 7.88% | Mar 3, 2024 | 2y |
| David A. Lorber | PFX PhenixFIN Corp | 13D/A | 10.1% | Mar 1, 2024 | 2y |
| Bellevue Capital Partners, LLC | NYC American Strategic Investment Co. | 13D/A | 48.1% | Mar 1, 2024 | 2y |
| GOLDMAN SACHS GROUP INC | QBTS D-Wave Quantum Inc. | 13G/A | 1.9% | Mar 1, 2024 | 2y |
| Shoshana Shendelman | APLT Applied Therapeutics, Inc. Common Stock | 13D/A | 8.2% | Mar 1, 2024 | 2y |
| Madison Square Garden Entertainment Corp. | TSQ Townsquare Media, Inc. | 13D/A | 11.5% | Mar 1, 2024 | 2y |
| Carlyle Group Management L.L.C. | CG Carlyle Group Inc. | 13D/A | 39% | Mar 1, 2024 | 2y |
| Cano Health, Inc. | MSPR MSP Recovery, Inc. | 13D/A | 20.1% | Mar 1, 2024 | 2y |
| Redmile Group, LLC | ABSI Absci Corp | 13D/A | 7.4% | Mar 1, 2024 | 2y |
| Saba Capital Management, L.P. | SABA Saba Capital Income & Opportunities Fund II | 13D/A | 14.29% | Mar 1, 2024 | 2y |
| CHAI TRUST CO LLC | PARR Par Pacific Holdings, Inc. | 13D/A | 3.7% | Mar 1, 2024 | 2y |